Complementary and Alternative Medicine for Sleep Disturbances in Older Adults

Clinics in Geriatric Medicine

Volumn 24, Issue 1, 2008, Pages 121-138

  Gooneratne, Nalaka S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FOLLITROPIN; GLUTAMINE; HYPNOTIC SEDATIVE AGENT; LUTEINIZING HORMONE; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZEPAM; SOMATOMEDIN C; THYROTROPIN; VALEPOTRIATE; VALERIAN;

ACUPRESSURE; ACUPUNCTURE; AGING; ALTERNATIVE MEDICINE; AYURVEDA; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTACT ALLERGY; DAYTIME SOMNOLENCE; DRUG DEPENDENCE; DRUG EFFICACY; EUPHORIA; EVENING DOSAGE; FEEDBACK SYSTEM; GASTROINTESTINAL SYMPTOM; HEADACHE; HOMEOPATHY; HUMAN; INSOMNIA; MANIPULATIVE MEDICINE; MASSAGE; MEDITATION; MYDRIASIS; NONHUMAN; REVIEW; SIDE EFFECT; SLEEP DISORDER; SLEEP WAKING CYCLE; TAI CHI; TREATMENT INDICATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; YOGA; AGED; ANIMAL; BLOOD; PHYSIOLOGY; PHYTOTHERAPY;

ACUPRESSURE; AGED; ANIMALS; CIRCADIAN RHYTHM; COMPLEMENTARY THERAPIES; HUMANS; MEDITATION; MELATONIN; PHYTOTHERAPY; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TAI JI; VALERIAN; YOGA;

EID: 38949166904     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.08.002     Document Type: Review

References (125)

1. Natural Standard Research Collaboration. Valerian (Valeriana officinalis L.). [internet] Oct 1, 2006. Available at: http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-valerian.htm l. Accessed May 20, 2007.
2. National Center for Complementary and Alternative Medicine. What Is CAM? NCCAM Publication No. D347. [internet] February 2007. Available at: http://nccam.nih.gov/health/whatiscam/. Accessed June 1, 2007.
3. Meoli A.L., Rosen C.L., Kristo D., et al. Non-Pharmacologic Treatments for Insomnia. J Clin Sleep Med 1 (2005) 173-187
4. Shimazaki M., and Martin J.L. Do herbal agents have a place in the treatment of sleep problems in long-term care?. J Am Med Dir Assoc 8 4 (2007) 248-252
5. Bent S., Padula A., Moore D., et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med 119 12 (2006) 1005-1012
6. Stevinson C., and Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 1 2 (2000) 91-99
7. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 19 4 (2005) 414-421
8. Management of insomnia: a place for traditional herbal remedies. Prescrire Int 14 77 (2005) 104-107
9. Sok S.R., Erlen J.A., and Kim K.B. Effects of acupuncture therapy on insomnia. J Adv Nurs 44 4 (2003) 375-384
10. Larzelere M.M., and Wiseman P. Anxiety, depression, and insomnia. Prim Care 29 2 (2002) 339-360 vii
11. Crofford L.J., and Appleton B.E. Complementary and alternative therapies for fibromyalgia. Curr Rheumatol Rep 3 2 (2001) 147-156
12. Gyllenhaal C., Merritt S.L., Peterson S.D., et al. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev 4 3 (2000) 229-251
13. Vallbona C., and Richards T. Evolution of magnetic therapy from alternative to traditional medicine. Phys Med Rehabil Clin N Am 10 3 (1999) 729-754
14. Lin Y. Acupuncture treatment for insomnia and acupuncture analgesia. Psychiatry Clin Neurosci 49 2 (1995) 119-120
15. American Association of Retired Persons, National Center for Complementary and Alternative Medicine. Complementary and Alternative Medicine: what People 50 and Over Are Using and Discussing with Their Physicians (2007), AARP, Washington, D.C.
16. Pearson N.J., Johnson L.L., and Nahin R.L. Insomnia, trouble sleeping, and complementary and alternative medicine: analysis of the 2002 national health interview survey data. Arch Intern Med 166 16 (2006) 1775-1782
17. Hatoum H.T., Kania C.M., Kong S.X., et al. Prevalence of insomnia: a survey of the enrollees at five managed care organizations. Am J Manag Care 4 1 (1998) 79-86
18. Stewart R., Besset A., Bebbington P., et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 29 11 (2006) 1391-1397
19. Zhdanova I.V. Melatonin as a hypnotic: pro. Sleep Med Rev 9 1 (2005) 51-65
20. Brzezinksi A. Melatonin in Humans. N Engl J Med 336 3 (1997) 186
21. Sack R.L., Brandes R.W., Kendall A.R., et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 343 15 (2000) 1070-1077
22. Dubocovitch M. Melatonin receptors: are there multiple subtypes?. Trends Pharmacol Sci 16 (1995) 50-56
23. Liu C., Weaver D.R., Jin X., et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19 1 (1997) 91-102
24. Mendelson W.B. Melatonin microinjection into the medial preoptic area increases sleep in the rat. Life Sci 71 17 (2002) 2067-2070
25. Zhou J.N., Liu R.Y., Van Heerikhuize J., et al. Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res 34 1 (2003) 11-16
26. Touitou Y., Fevre M., Lagoguey M., et al. Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J Endocrinol 91 3 (1981) 467-475
27. Sharma M., Palacios-Bois J., Schwartz G., et al. Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 25 3 (1989) 305-319
28. Humbert W., and Pevet P. Calcium content and concretions of pineal glands of young and old rats. A scanning and X-ray microanalytical study. Cell Tissue Res 263 3 (1991) 593-596
29. Kripke D.F., Elliot J.A., Youngstedt S.D., et al. Melatonin: marvel or marker?. Ann Med 30 1 (1998) 81-87
30. Riemann D., Klein T., Rodenbeck A., et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 113 1-2 (2002) 17-27
31. Hajak G., Rodenbeck A., Staedt J., et al. Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J Pineal Res 19 3 (1995) 116-122
32. Youngstedt S.D., Kripke D.F., Elliott J.A., et al. Circadian abnormalities in older adults. J Pineal Res 31 3 (Oct 2001) 264-272
33. Lushington K., Dawson D., Kennaway D.J., et al. The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 years. J Sleep Res 8 1 (1999) 57-64
34. Baskett J.J., Wood P.C., Broad J.B., et al. Melatonin in older people with age-related sleep maintenance problems: a comparison with age matched normal sleepers. Sleep 24 4 (2001) 418-424
35. Van Den Heuvel C.J., Reid K.J., and Dawson D. Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. Physiol Behav 61 6 (1997) 795-802
36. Murphy P.J., Myers B.L., and Badia P. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59 1 (1996) 133-139
37. Surrall K., Smith J.A., Bird H., et al. Effect of ibuprofen and indomethacin on human plasma melatonin. J Pharm Pharmacol 39 10 (1987) 840-843
38. Almay B.G., von Knorring L., and Wetterberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res 22 3 (1987) 179-191
39. Brugger P., Marktl W., and Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 345 8962 (1995) 1408
40. Fiorina P., Lattuada G., Silvestrini C., et al. Disruption of nocturnal melatonin rhythm and immunological involvement in ischaemic stroke patients. Scand J Immunol 50 2 (1999) 228-231
41. Richardson G., and Tate B. Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies. Sleep 23 Suppl 3 (2000) S77-S85
42. Garfinkel D., Laudon M., Nof D., et al. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346 8974 (1995) 541-544
43. Jean-Louis G., von Gizycki H., and Zizi F. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 25 3 (1998) 177-183
44. Baskett J.J., Broad J.B., Wood P.C., et al. Does melatonin improve sleep in older people? A randomised crossover trial. Age Ageing 32 2 (2003) 164-170
45. Singer C., Tractenberg R.E., Kaye J., et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 26 7 (2003) 893-901
46. Zhdanova I.V., Wurtman R.J., Regan M.M., et al. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 86 10 (2001) 4727-4730
47. Monti J.M., Alvarino D., Cardinali D., et al. Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia. Arch Gerontol Geriatr 28 (1999) 85-98
48. Hughes R.J., Sack R.L., and Lewy A.J. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 21 1 (1998) 52-68
49. Dawson D., Rogers N.L., van den Heuvel C.J., et al. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. J Biol Rhythms 13 6 (1998) 532-538
50. Buscemi N, Vandermeer B, Pandya R, et al. Melatonin for Treatment of Sleep Disorders, Evidence Report/Technology Assessment No. 108. Rockville, MD: agency for Healthcare Research and Quality. Prepared by the University of Alberta Evidence-based Practice Center, under Contract No. 290-02-0023; November 2004. AHRQ Publication No. 05-E002-2.
51. Haimov I., Lavie P., Laudon M., et al. Melatonin replacement therapy of elderly insomniacs. Sleep 18 7 (1995) 598-603
52. Leger D., Laudon M., and Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 116 2 (2004) 91-95
53. Siegrist C., Benedetti C., Orlando A., et al. Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients. J Pineal Res 30 1 (2001) 34-42
54. Seabra M.L., Bignotto M., Pinto Jr. L.R., et al. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 29 4 (2000) 193-200
55. Buscemi N., Vandermeer B., Hooton N., et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 20 12 (2005) 1151-1158
56. Mendelson W.B. A critical evaluation of the hypnotic efficacy of melatonin. Sleep 20 10 (1997) 916-919
57. Rogers N.L., Phan O., Kennaway D.J., et al. Effect of daytime oral melatonin administration on neurobehavioral performance in humans. J Pineal Res 25 1 (1998) 47-53
58. Okawa M., Uchiyama M., Ozaki S., et al. Melatonin treatment for circadian rhythm sleep disorders. Psychiatry Clin Neurosci 52 2 (1998) 259-260
59. Middleton B.A., Stone B.M., and Arendt J. Melatonin and fragmented sleep patterns. Lancet 348 9026 (1996) 551-552
60. Dawson D., and van den Heuvel C.J. Integrating the actions of melatonin on human physiology. Ann Med 30 1 (1998) 95-102
61. Lusardi P., Piazza E., and Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol 49 5 (2000) 423-427
62. Sewerynek E. Melatonin and the cardiovascular system. Neuroendocrinol Lett 23 Suppl 1 (2002) 79-83
63. Maestroni G.J. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs 10 3 (2001) 467-476
64. Hansson I., Holmdahl R., and Mattsson R. Constant darkness enhances autoimmunity to type II collagen and exaggerates development of collagen-induced arthritis in DBA/1 mice. J Neuroimmunol 27 1 (1990) 79-84
65. Maestroni G.J., Sulli A., Pizzorni C., et al. Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966 (2002) 271-275
66. Conti A., and Maestroni G.J. Melatonin rhythms in mice: role in autoimmune and lymphoproliferative diseases. Ann N Y Acad Sci 840 (1998) 395-410
67. Bilici D., Akpinar E., and Kiziltunc A. Protective effect of melatonin in carrageenan-induced acute local inflammation. Pharmacol Res 46 2 (2002) 133-139
68. Hong Y.G., and Riegler J.L. Is melatonin associated with the development of autoimmune hepatitis?. J Clin Gastroenterol 25 1 (1997) 376-378
69. Medical Letter. Melatonin. Med Lett Drugs Ther 37 962 (1995) 111-112
70. Leibenluft E., Feldman-Naim S., Turner E.H., et al. Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder. J Clin Psychiatry 58 9 (1997) 383-388
71. Maksoud A., Moore C.A., and Harshkowitz M. The effect of melatonin administration on patients with sleep apnea. Sleep Research 26 (1997) 114
72. Olde Rikkert M.G., and Rigaud A.S. Melatonin in elderly patients with insomnia. A systematic review. Z Gerontol Geriatr 34 6 (2001) 491-497
73. Bellipanni G., Bianchi P., Pierpaoli W., et al. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol 36 2 (2001) 297-310
74. Attele A.S., Xie J.T., and Yuan C.S. Treatment of insomnia: an alternative approach. Altern Med Rev 5 3 (2000) 249-259
75. Pawlikowski M., Kolomecka M., Wojtczak A., et al. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuroendocrinol Lett 23 Suppl 1 (2002) 17-19
76. National Academies-Committee on the Framework for Evaluating the Safety of Dietary Supplements. Prototype Monograph on Melatonin. Dietary supplements: a framework for evaluation safety (2004), The National Academies Press, Washington, D.C. p. D1-71
77. Houghton P.J. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 51 5 (1999) 505-512
78. Santos M.S., Ferreira F., Cunha A.P., et al. Synaptosomal GABA release as influenced by valerian root extract-involvement of the GABA carrier. Arch Int Pharmacodyn Ther 327 2 (1994) 220-231
79. Muller C.E., Schumacher B., Brattstrom A., et al. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci 71 16 (2002) 1939-1949
80. Dietz B.M., Mahady G.B., Pauli G.F., et al. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res 138 2 (2005) 191-197
81. ConsumerLab.com. Valerian: product review. Available at: www.consumerlab.com. Accessed May 20, 2007.
82. Balderer G., and Borbely A.A. Effect of valerian on human sleep. Psychopharmacology 87 4 (1985) 406-409
83. Leathwood P.D., and Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med 51 2 (1985) 144-148
84. Donath F., Quispe S., Diefenbach K., et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33 2 (2000) 47-53
85. Leathwood P.D., Chauffard F., Heck E., et al. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 17 1 (1982) 65-71
86. Poyares D.R., Guilleminault C., Ohayon M.M., et al. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?. Prog Neuropsychopharmacol Biol Psychiatry 26 3 (2002) 539-545
87. Ziegler G., Ploch M., Miettinen-Baumann A., et al. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia-a randomized, double-blind, comparative clinical study. Eur J Med Res 7 11 (2002) 480-486
88. Schulz H., Stolz C., and Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry 27 4 (1994) 147-151
89. Diaper A., and Hindmarch I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytother Res 18 10 (2004) 831-836
90. PDR for Herbal Remedies (1998), Medical Economics, Montvale (NJ)
91. Morin C.M., Koetter U., Bastien C., et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 28 11 (2005) 1465-1471
92. Block K.I., Gyllenhaal C., and Mead M.N. Safety and efficacy of herbal sedatives in cancer care. Integr Cancer Ther 3 2 (2004) 128-148
93. Taibi D.M., Bourguignon C., and Taylor A.G. Valerian use for sleep disturbances related to rheumatoid arthritis. Holist Nurs Pract 18 3 (2004) 120-126
94. Richards K., Nagel C., Markie M., et al. Use of complementary and alternative therapies to promote sleep in critically ill patients. Crit Care Nurs Clin North Am 15 3 (2003) 329-340
95. Plushner S.L. Valerian: valeriana officinalis. Am J Health Syst Pharm 57 4 (2000) 328, 333, 335
96. Kuhlmann J., Berger W., Podzuweit H., et al. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry 32 6 (1999) 235-241
97. Garges H.P., Varia I., and Doraiswamy P.M. Cardiac complications and delirium associated with valerian root withdrawal. [letter]. JAMA 280 18 (1998) 1566-1567
98. Soden K., Vincent K., Craske S., et al. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 18 2 (2004) 87-92
99. Hanley J., Stirling P., and Brown C. Randomised controlled trial of therapeutic massage in the management of stress. Br J Gen Pract 53 486 (2003) 20-25
100. McDowell J.A., Mion L.C., Lydon T.J., et al. A nonpharmacologic sleep protocol for hospitalized older patients. J Am Geriatr Soc 46 6 (1998) 700-705
101. Richards K.C. Effect of a back massage and relaxation intervention on sleep in critically ill patients. Am J Crit Care 7 4 (1998) 288-299
102. Field T., Diego M., Cullen C., et al. Fibromyalgia Pain and substance p decrease and sleep improves after massage therapy. J Clin Rheumatol 8 2 (2002) 72-76
103. Sarac A.J., and Gur A. Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des 12 1 (2006) 47-57
104. Chen M.L., Lin L.C., Wu S.C., et al. The effectiveness of acupressure in improving the quality of sleep of institutionalized residents. J Gerontol A Biol Sci Med Sci 54 8 (1999) M389-M394
105. Tsay S.L., and Chen M.L. Acupressure and quality of sleep in patients with end-stage renal disease-a randomized controlled trial. Int J Nurs Stud 40 1 (2003) 1-7
106. Tsay S.L., Cho Y.C., and Chen M.L. Acupressure and Transcutaneous Electrical Acupoint Stimulation in improving fatigue, sleep quality and depression in hemodialysis patients. Am J Chin Med 32 3 (2004) 407-416
107. Yang M.H., Wu S.C., Lin J.G., et al. The efficacy of acupressure for decreasing agitated behaviour in dementia: a pilot study. J Clin Nurs 16 2 (2007) 308-315
108. Suen L.K., Wong T.K., Leung A.W., et al. The long-term effects of auricular therapy using magnetic pearls on elderly with insomnia. Complement Ther Med 11 2 (2003) 85-92
109. Suen L.K., Wong T.K., and Leung A.W. Effectiveness of auricular therapy on sleep promotion in the elderly. Am J Chin Med 30 4 (2002) 429-449
110. Spence D.W., Kayumov L., Chen A., et al. Acupuncture increases nocturnal melatonin secretion and reduces insomnia and anxiety: a preliminary report. J Neuropsychiatry Clin Neurosci 16 1 (2004) 19-28
111. Montakab H. [Acupuncture and insomnia]. Forsch Komplementarmed 6 Suppl 1 (1999) 29-31
112. Kim Y.S., Lee S.H., Jung W.S., et al. Intradermal acupuncture on shen-men and nei-kuan acupoints in patients with insomnia after stroke. Am J Chin Med 32 5 (2004) 771-778
113. Huang M.I., Nir Y., Chen B., et al. A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 86 3 (2006) 700-710
114. Carpenter J.S., and Neal J.G. Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology, and homeopathy. Am J Med 118 Suppl 12B (2005) 109-117
115. Rooks D.S. Fibromyalgia treatment update. Curr Opin Rheumatol 19 2 (2007) 111-117
116. Holdcraft L.C., Assefi N., and Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 17 4 (2003) 667-683
117. Freire A.O., Sugai G.C., Chrispin F.S., et al. Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Med 8 1 (2007) 43-50
118. Wang X.H., Yuan Y.D., and Wang B.F. [Clinical observation on effect of auricular acupoint pressing in treating sleep apnea syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 10 (2003) 747-749
119. Mason L.I., Alexander C.N., Travis F.T., et al. Electrophysiological correlates of higher states of consciousness during sleep in long-term practitioners of the Transcendental Meditation program. Sleep 20 2 (1997) 102-110
120. Smith J.E., Richardson J., Hoffman C., et al. Mindfulness-Based Stress Reduction as supportive therapy in cancer care: systematic review. J Adv Nurs 52 3 (2005) 315-327
121. Carlson L.E., and Garland S.N. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 12 4 (2005) 278-285
122. Manjunath N.K., and Telles S. Influence of Yoga and Ayurveda on self-rated sleep in a geriatric population. Indian J Med Res 121 5 (2005) 683-690
123. Cohen L., Warneke C., Fouladi R.T., et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100 10 (2004) 2253-2260
124. Bower J.E., Woolery A., Sternlieb B., et al. Yoga for cancer patients and survivors. Cancer Control 12 3 (2005) 165-171
125. Li F., Fisher K.J., Harmer P., et al. Tai Chi and self-rated quality of sleep and daytime sleepiness in older adults: a randomized controlled trial. J Am Geriatr Soc 52 6 (2004) 892-900